To Better Understand the Most Important Factors for Patients When They Decide on the Type of Treatment They Receive for Muscle Invasive Bladder Cancer (MIBC).
Clinical trial NCT05236218 · UNKNOWN
Trial details
- NCT number
- NCT05236218
- Sponsor
- King's College London
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-20
- Primary completion
- 2023-04-25
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.